[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366824-105":59,"doc-detail-366824-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-clinical-significance-of-extrapancreatic-incidental-findings-detected-during-pancreas-surveillance","The Clinical Significance of Extrapancreatic Incidental Findings Detected During Pancreas Surveillance","","Cancer surveillance in high-risk individuals can detect cancers and precancerous conditions, but incidental findings may trigger unnecessary and potentially harmful diagnostic evaluations or treatments. This study assessed the diagnostic yield of extrapancreatic incidental findings requiring management during pancreatic surveillance in 925 patients from the Johns Hopkins CAPS studies. Outcomes included characterization of cancers, precancerous lesions, and other concerning findings, along with diagnostic tests, interventions, complications, and retrospective overtreatment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-clinical-significance-of-extrapancreatic-incidental-findings-detected-during-pancreas-surveillance/366824/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-clinical-significance-of-extrapancreatic-incidental-findings-detected-during-pancreas-surveillance/366824.png","ImageObject",300,407,{"name":92,"@type":93},"PakDamar76","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s primary goal?","Question",{"text":112,"@type":113},"To determine the yield of extrapancreatic incidental findings that required management during pancreatic surveillance in patients with familial or genetic pancreatic cancer risk, including cancers, precancerous lesions, and other diagnostically concerning findings.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many extrapancreatic incidental findings were detected, and what did they include?",{"text":117,"@type":113},"Seventy-five extrapancreatic incidental findings were detected in 68 patients (7.3%), including 10 cancers and 8 precancerous lesions (0.86%). Most cancers were stage I.",{"name":119,"@type":110,"acceptedAnswer":120},"Did incidental findings often lead to unnecessary treatment?",{"text":121,"@type":113},"Few interventions were unnecessary. In retrospect, only three patients (0.33%) were considered overtreated, and almost all interventions were for cancerous or precancerous lesions.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366824,1790535199,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},962090893057,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Gastro Hep Advances 2026;5:100818  \nORIGINAL RESEARCH—CLINICAL   \nThe Clinical Significance of Extrapancreatic Incidental Findings Detected During Pancreas Surveillance  \nHelena Saba,1 Elizabeth Abou Diwan, 1 Hassan Sinan, 1 Dimitri Melki,1 Mohamad Dbouk, 1 Amanda Blackford,2 Linda Chu,3 Eun Ji Shin,2 Marcia Irene Canto,2 ,4 and Michael Goggins 1 ,2 ,4  \n1Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland; 2Department of Oncology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland; 3Department of Radiology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland; and 4Department of Medicine, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Medical Institutions, Baltimore, Maryland.  \nBACKGROUND AND AIMS: Cancer screening tests have the potential to detect cancers and precancerous conditions, but one concern is the potential that screen-detected incidental findings lead to unnecessary, potentially harmful interventions. The aim of this study is to determine, the yield of extrapancreatic incidental findings that required management, including cancers, precancerous lesions, and other findings of diagnostic concern in patients undergoing pancreatic surveillance for their familial or genetic pancreatic cancer risk. METHODS: We reviewed the pancreatic surveillance records of 925 patients enrolled in the Cancer of Pancreas Screening studies at The Johns Hopkins Hospital from 1998 to 2023 who had undergone at least one pancreatic surveillance test. Significant extra-pancreatic incidental findings that required diagnostic evaluation and/or treatment were tabulated, including the resulting diagnostic tests, therapeutic interventions, and complications. RESULTS: The mean age/standard deviation at enrollment, of patients in the cohort was 58.0/10.4 years; 59.7% female), 220 (23.8%) had undergone baseline surveillance, 705 (76.2%) had undergone surveillance for a median of 4 years. Seventy-five extrapancreatic incidental findings were detected in 68 patients (7.3%), including 10 cancers, 80% of which were stage I and 8 (0.86%) precancerous lesions. Thirteen patients underwent surgical (n = 13), endoscopic (n = 9), or chemotherapy (n = 4) . Twenty-five patients (2.7%) were recommended to undergo surveillance, (20 for nondysplastic Barrett’s esophagus) . Three patients (0.33%) were considered overtreated in retrospect (2 cholecystectomies, 1 partial nephrectomy, all laparoscopic) . One patient had a postoperative complication treated successfully. CONCLUSION: Extrapancreatic incidental findings are commonly detected in patients undergoing pancreatic surveillance, but few signify serious pathology. Almost all interventions for incidental findings were for cancerous and precancerous lesions, with few instances of unnecessary interventions.  \nKeywords: cancer screening; incidentalomas; overdiagnosis; overtreatment  \nIntroduction  \nRecent studies, based on  \nyears of experience,  \nthe accumulation of ∼25 have demonstrated that  \npancreatic surveillance of high-risk individuals can result in down-staging of pancreatic cancers diagnosed, with the majority of screen-detected pancreatic cancers diagnosed at stage I disease, and long-term survival in most patients.1–5  \nMany individuals who undergo pancreatic surveillance are at increased risk for other cancers. The tests used for surveillance endoscopic ultrasound (EUS) and magnetic resonance imaging (MRI)/magnetic retrograde cholangiopancreatography,6–8 not only have the potential to detect other cancers, they often uncover incidental findings.  \nThe diagnostic yield of EUS and MRI for pancreatic lesions in patients undergoing pancreatic surveillance has been extensively studied,9–14 but the significance of nonpancreatic incidental findings identified during pancreatic surveillance has not been ext","cbCaij6neDteJCVo","https://ap.wps.com/l/cbCaij6neDteJCVo","pdf",540333,"English","# Background and Aims\n# Methods\n## Study Design and Patients\n# Results\n# Conclusion","[{\"question\":\"What was the study’s primary goal?\",\"answer\":\"To determine the yield of extrapancreatic incidental findings that required management during pancreatic surveillance in patients with familial or genetic pancreatic cancer risk, including cancers, precancerous lesions, and other diagnostically concerning findings.\"},{\"question\":\"How many extrapancreatic incidental findings were detected, and what did they include?\",\"answer\":\"Seventy-five extrapancreatic incidental findings were detected in 68 patients (7.3%), including 10 cancers and 8 precancerous lesions (0.86%). Most cancers were stage I.\"},{\"question\":\"Did incidental findings often lead to unnecessary treatment?\",\"answer\":\"Few interventions were unnecessary. In retrospect, only three patients (0.33%) were considered overtreated, and almost all interventions were for cancerous or precancerous lesions.\"}]","The Clinical Significance of Extrapancreatic Incidental Findings Detected During Pancreas Surveillance | PDF",1790167794,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16f2601c7bba162ba45fc5fb9fb2ba7b.webp",983,1296,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ee322eb3984cacae98a06068e8261c5.webp",982,1294,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/53a07b74b9405d6b498eefa60ef05793.webp",981,1293,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ae35f7965839025defc86dc73357335.webp",980,742]